Jpmorgan Chase & Co »

Apellis Pharmaceuticals Inc call shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Apellis Pharmaceuticals Inc call shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Apellis Pharmaceuticals Inc call

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals Inc call held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals Inc call by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.7M 62k 59.86
2023-09-30 $21M 556k 38.04
2023-06-30 $7.8M 85k 91.10
2023-03-31 $24M 365k 65.96
2022-12-31 $207k 4.0k 51.75
2022-03-31 $8.4M 166k 50.81
2021-03-31 $232k 5.4k 42.96
2019-12-31 $6.3M 207k 30.62

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Apellis Pharmaceuticals Inc call

Jane Street
SG Americas Securities
Simplex Trading
Jpmorgan Chase & Co
Picton Mahoney Asset Management

View all funds holding Apellis Pharmaceuticals Inc call